Today, the Supreme Court temporarily allowed continued nationwide access to abortion medication

that's often distributed by mail.

The court issued a one-week stay on a lower court's ruling that would have led to sweeping changes

in how Mithopristone, one of the two drugs commonly used, can be prescribed.

That ruling would require an in-person doctor's visit before the pills could be prescribed.

For more on the ruling and what comes next, I'm joined now by Mary Ziegler. She's a professor at the

University of California, Davis School of Law. Mary Ziegler, welcome back to the News Hour. So just walk us

through here exactly what the Supreme Court temporarily paused today. What was the federal court's

decision that was put on hold? So the Fifth Circuit Court of Appeals had put in immediate stop

nationwide telehealth access to the pill Mipha Pristone, which is used in more than two-thirds

of all abortions nationwide. And we have data to suggest that at least a quarter,

more than a quarter of all abortions nationwide now involved telehealth. That number is likely

an undercount given that some of these procedures are illegal. So we were talking about a significant

number of people losing access to abortion, particularly in states where abortion is a crime and where patients were relying on

that telehealth access. So the Supreme Court issued a one-week hold, essentially restores access

to Mithiphrastone through telehealth and mail and through pharmacies. What happens during that

week and what happens when the week is over? Well, this week should be pretty quiet. The one thing

we're watching this week is that we're waiting to see what the Trump administration is going to do.

This is an unusual case because Louisiana, a Republican state, is suing the Trump FDA,

essentially to force a change on the regulations governing Mitha Pristone. And we have yet to hear

what the Trump administration is going to say. So we're waiting to see how the Trump administration tries to walk

that tightrope between pleasing base voters on the one hand and not potentially alienating swing

...